This inventor holds 2 USPTO granted patents. Top assignee: Anticancer, Inc.. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2005
Title: Kenji Miki: Innovator in Cancer Therapy
Introduction
Kenji Miki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer therapy through his innovative research and development of selenium-containing pro-drugs. With a total of 2 patents, Miki's work focuses on enhancing the effectiveness of anti-tumor agents.
Latest Patents
Miki's latest patents describe methods for inhibiting the growth of tumor cells by utilizing a combination treatment with a selenium-containing pro-drug and an enzyme for which it serves as a substrate. This innovative approach not only targets tumor cells but also enhances the effects of existing anti-tumor agents, providing a promising avenue for cancer treatment.
Career Highlights
Kenji Miki is currently associated with Anticancer, Inc., where he continues to push the boundaries of cancer research. His dedication to developing effective therapies has positioned him as a key figure in the fight against cancer.
Collaborations
Miki collaborates with talented individuals such as Mingxu Xu and Yuying Tan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kenji Miki's work in developing selenium-containing pro-drugs represents a significant advancement in cancer therapy. His innovative approach and collaboration with other experts highlight the importance of teamwork in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile